Business Description
West Pharmaceutical Services Inc
NAICS : 339112
SIC : 3841
ISIN : US9553061055
Description
Financial Strength
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.61 | |||||
Equity-to-Asset | 0.75 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | 0.41 | |||||
Interest Coverage | 117.56 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 18.64 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.4 | |||||
3-Year EBITDA Growth Rate | 17.9 | |||||
3-Year EPS without NRI Growth Rate | 19.3 | |||||
3-Year FCF Growth Rate | 11.9 | |||||
3-Year Book Growth Rate | 16.1 | |||||
Future 3-5Y Total Revenue Growth Rate | 4.2 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 57.05 | |||||
9-Day RSI | 58.48 | |||||
14-Day RSI | 57.96 | |||||
6-1 Month Momentum % | -1.68 | |||||
12-1 Month Momentum % | -9.56 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3 | |||||
Quick Ratio | 2.23 | |||||
Cash Ratio | 0.95 | |||||
Days Inventory | 82.49 | |||||
Days Sales Outstanding | 64.94 | |||||
Days Payable | 44.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.24 | |||||
Dividend Payout Ratio | 0.12 | |||||
3-Year Dividend Growth Rate | 5.8 | |||||
Forward Dividend Yield % | 0.25 | |||||
5-Year Yield-on-Cost % | 0.32 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 3.16 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.87 | |||||
Operating Margin % | 20.44 | |||||
Net Margin % | 17.37 | |||||
FCF Margin % | 11.16 | |||||
ROE % | 18.16 | |||||
ROA % | 13.61 | |||||
ROIC % | 18.1 | |||||
ROC (Joel Greenblatt) % | 27.61 | |||||
ROCE % | 19.14 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 48.9 | |||||
Forward PE Ratio | 44.16 | |||||
PE Ratio without NRI | 48.75 | |||||
Shiller PE Ratio | 62.08 | |||||
Price-to-Owner-Earnings | 57.38 | |||||
PEG Ratio | 2.22 | |||||
PS Ratio | 8.48 | |||||
PB Ratio | 8.68 | |||||
Price-to-Tangible-Book | 9.08 | |||||
Price-to-Free-Cash-Flow | 75.9 | |||||
Price-to-Operating-Cash-Flow | 34.75 | |||||
EV-to-EBIT | 40.56 | |||||
EV-to-Forward-EBIT | 35.72 | |||||
EV-to-EBITDA | 32.29 | |||||
EV-to-Forward-EBITDA | 28.29 | |||||
EV-to-Revenue | 8.28 | |||||
EV-to-Forward-Revenue | 7.72 | |||||
EV-to-FCF | 74.05 | |||||
Price-to-Projected-FCF | 3.45 | |||||
Price-to-DCF (Earnings Based) | 1.61 | |||||
Price-to-DCF (FCF Based) | 2.51 | |||||
Price-to-Median-PS-Value | 1.39 | |||||
Price-to-Peter-Lynch-Fair-Value | 3.05 | |||||
Price-to-Graham-Number | 4.44 | |||||
Price-to-Net-Current-Asset-Value | 38.05 | |||||
Earnings Yield (Greenblatt) % | 2.47 | |||||
FCF Yield % | 1.35 | |||||
Forward Rate of Return (Yacktman) % | 17.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
West Pharmaceutical Services Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 2,636.22 | ||
EPS (TTM) (€) | 6.174 | ||
Beta | 0.74 | ||
Volatility % | 24.33 | ||
14-Day RSI | 57.96 | ||
14-Day ATR (€) | 4.993592 | ||
20-Day SMA (€) | 306.17 | ||
12-1 Month Momentum % | -9.56 | ||
52-Week Range (€) | 253.7 - 386.2 | ||
Shares Outstanding (Mil) | 72.42 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
West Pharmaceutical Services Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
West Pharmaceutical Services Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
West Pharmaceutical Services Inc Frequently Asked Questions
What is West Pharmaceutical Services Inc(STU:WPS)'s stock price today?
When is next earnings date of West Pharmaceutical Services Inc(STU:WPS)?
Does West Pharmaceutical Services Inc(STU:WPS) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |